12221201000001100: Incruse Ellipta (product)

SNOMED CT Concept\Pharmaceutical / biologic product\UK product\Trade family\Incruse Ellipta

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

87524801000001119 Incruse Ellipta en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

87524901000001113 Incruse Ellipta (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Incruse Ellipta	Is a	Trade family	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)	Is a	True	Incruse Ellipta	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets